Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study.
Journal: American journal of hematology
Published: August 06, 2021
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.
Journal: Kidney international reports
Published: December 16, 2020
Roxadustat for CKD-related Anemia in Non-dialysis Patients.
Journal: Kidney international reports
Published: November 12, 2020
Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 10, 2020
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
Journal: The New England journal of medicine
Published: July 25, 2019
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Journal: The New England journal of medicine
Published: July 25, 2019
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: June 25, 2015
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: May 07, 2015
Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.
Journal: Journal of the American Society of Nephrology : JASN
Published: March 04, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026